Echinococcus granulosus is a zoonotic parasite causing hydatidosis in humans and animals. This study has been done in order to investigate the effect of albendazole nanocrystals on the viability of E. granulosus protoscolices. The average size and hydrodynamic diameter of albendazole nanocrystals were 976±218 and 1334±502 nm, respectively. Fertile hydatid cysts were isolated from the liver of slaughtered sheep. The isolated cysts were further identified using morphological and molecular techniques. The nucleotide sequence analysis indicated that the genotype of the protoscolices was E. granulosus sensu stricto with 100% similarity. The parasites were examined precisely for susceptibility to albendazole nanocrystals. The results revealed that albendazole nanocrystals are effective in removing protoscolices. It was observed that 1 μg/ml albendazole nanocrystals and albendazole completely inhibited the viability of the protoscolices within 17 and 23 days, respectively. The results suggested that albendazole nanocrystals can be used as an alternative effective treatment for E. granulosus infection.

Download full-text PDF

Source
http://dx.doi.org/10.17420/ap6702.330DOI Listing

Publication Analysis

Top Keywords

albendazole nanocrystals
28
albendazole
8
echinococcus granulosus
8
granulosus protoscolices
8
nanocrystals
7
granulosus
5
protoscolices
5
vitro evaluation
4
evaluation albendazole
4
nanocrystals echinococcus
4

Similar Publications

Background: Cystic echinococcosis (CE) is a common neglected parasitic disease. Nanoparticles containing drugs have been widely utilized in various formulations for several purposes, including improving the bioavailability of drugs by increasing the solubility and dissolution rate of the nanoparticles. The purpose of this study was to evaluate the effects of solid lipid nanoparticles containing albendazole and conjugated to albumin (B-SLN + ABZ) as a novel treatment approach for hydatid cysts in vivo.

View Article and Find Full Text PDF

In vivo pharmacokinetic study and PBPK modeling: Comparison between 3D-printed nanocrystals and solid dispersions.

Int J Pharm

December 2024

Facultad de Ciencias Químicas, Universidad Nacional de Córdoba (FCQ-UNC), Haya de la Torre y Medina Allende, X5000XHUA Córdoba, Argentina; Unidad de Investigación y Desarrollo en Tecnología Farmacéutica (UNITEFA) - CONICET, Argentina. Electronic address:

The solubility of drugs remains one of the most challenging aspects of formulation development. Several technologies exist to enhance the properties of poorly soluble drugs, with nanocrystal (NC) and solid dispersion (SD) technologies being among the most important. This work compared NCs and SDs under identical conditions using albendazole as a model drug and 3D printing technology as the delivery method.

View Article and Find Full Text PDF

Background/objective: The primary treatment for cysts is surgery, including removing the cyst and administering the appropriate chemical drugs. Herbal remedies have gained popularity as a viable and secure alternative to conventional pharmaceuticals. It may be advantageous to use nanocapsules to overcome the bioavailability challenges associated with herbal remedies like curcumin.

View Article and Find Full Text PDF
Article Synopsis
  • Albendazole (ABZ), an existing anthelmintic drug, is being repurposed to treat colorectal cancer, but its effectiveness is hampered by poor solubility and low bioavailability.
  • To address this, researchers have developed a nanosuspension (NS) of ABZ using a dual centrifugation method with stabilizers and created nano-coated granules (NCG) for enhanced delivery.
  • The results showed that the ABZ nanosuspension and coated granules significantly improved drug release and demonstrated better tumor growth inhibition in colorectal cancer cell lines compared to conventional ABZ, highlighting their potential for targeted therapy.
View Article and Find Full Text PDF
Article Synopsis
  • Trichinellosis, a common parasitic disease, necessitates research into new treatments and the immune response, particularly involving myrrh extract and myrrh-based silver nanoparticles, which have been previously underexplored.
  • The study tested the effectiveness of biosynthesized silver nanoparticles, myrrh extract, and albendazole on infected mice, analyzing histopathological changes and immune markers after three days of treatment post-infection.
  • Results indicated a significant decrease in adult worm counts across all treatment groups, with the silver nanoparticles achieving an 88.64% mortality rate in adult worms, alongside notable intestinal alterations found in infected untreated mice.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!